Prognostic value of heart rate variability in patients with hypertrophic cardiomyopathy

Tatsuya Kawasaki1, Akihiro Azuma, Tomohiko Sakatani

  • 1Department of Cardiology, Matushita Memorial Hospital, Morigu-chi city, Osaka, Japan. js-k@wf6.so-net.ne.jp

Insights

Heart rate variability analysis predicts heart failure in hypertrophic cardiomyopathy (HCM) patients. The high frequency component of heart rate variability is a key indicator of cardiac events in HCM.

Area of Science:

  • Cardiology
  • Physiology
  • Medical Diagnostics

Background:

  • Hypertrophic cardiomyopathy (HCM) is associated with impaired heart rate variability (HRV).
  • The prognostic significance of HRV in HCM remains incompletely understood.
  • Previous studies suggest a link between HRV and clinical outcomes in cardiovascular diseases.

Purpose of the Study:

  • To investigate the prognostic value of HRV in a cohort of hypertrophic cardiomyopathy patients.
  • To determine if specific HRV parameters can predict adverse cardiac events, including heart failure and sudden death.
  • To identify independent predictors of cardiac events within the HCM population.

Main Methods:

  • Utilized fast Fourier transformation on 24-hour Holter recordings from 73 clinically stable HCM patients.
  • Calculated four spectral components of HRV: very low frequency, low frequency, high frequency, and total power.
  • Monitored patients for 28 months to record cardiac events such as death or hospitalization for heart failure.

Main Results:

  • Seven out of 73 HCM patients experienced cardiac events (death or heart failure hospitalization) during the follow-up period.
  • The high frequency (HF) component of HRV was significantly lower in patients who experienced cardiac events compared to those who did not (3.78 vs. 4.43 ln(ms(2)), P=.045).
  • Multivariate analysis identified the HF component as an independent predictor of cardiac events (RR=0.10, P=.023), while other HRV variables showed no significant differences.

Conclusions:

  • Heart rate variability analysis, particularly the high frequency component, is a valuable predictor of heart failure events in hypertrophic cardiomyopathy patients.
  • The prognostic value of HRV for predicting sudden death in HCM requires further investigation.
  • HRV assessment may aid in risk stratification and management of HCM patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...